Katoh T, Kaneko S, Takasawa S, Nagata N, Inatomi H, Ikemura K, Itoh H, Matsumoto T, Kawamoto T, Bell DA
Le transazioni avvengono su server criptati rispettando i massimi standard di sicurezza
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
doi: 10.1080/10408398.2020.1738333 185 AbbasiAAghebati-MalekiAYousefiMAghebati-MalekiL
(BPC stands for body protection compound.) Its purported benefits span healing ulcers, aiding muscle and tendon repair, regenerating nerves, countering neurodegeneration, and shielding from organ injury
KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition